Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Mital Jhaveri: Do Heart Failure Patients on Anticoagulants Still Need Aspirin?
Mital Jhaveri/LinkedIn
May 21, 2026, 12:38

Mital Jhaveri: Do Heart Failure Patients on Anticoagulants Still Need Aspirin?

Mital Jhaveri, Clinical Anticoagulation, Heart Failure Pharmacist at NYC HHC Queens Hospital Center, shared a post on LinkedIn about a recent article by Gilles Lemesle et al., published in NEJM, adding:

“A common question encountered in clinical practice is: ‘For my patient with chronic coronary syndrome, a stent, and heart failure who is on an anticoagulant, should I also continue aspirin?’

While the instinct may be to provide additional protection, recent evidence prompts a reevaluation.

The American Heart Association has referenced a significant trial published in the 2025 NEJM, which was halted early due to safety concerns.

This study involved nearly 900 adults with chronic coronary syndrome and stents, comparing those taking 100 mg of aspirin daily alongside prescribed anticoagulants to those on anticoagulants alone.

The findings were notable.

The addition of aspirin increased the risk of cardiovascular death, heart attack, stroke, systemic embolism, acute limb ischemia, and the need for coronary revascularization.

Furthermore, patients in the aspirin group experienced higher rates of major bleeding and mortality from any cause.

This research adds to the accumulating evidence that individuals taking aspirin in conjunction with anticoagulants face increased risks of cardiovascular events and major bleeding compared to those on anticoagulants alone.

The key takeaway for managing heart failure patients is clear: for individuals already on therapeutic anticoagulation, routinely adding aspirin may pose more risks than benefits, especially in heart failure contexts where bleeding risk is heightened.

The approach is shifting towards precision-duration, minimalist antithrombotic therapy rather than automatically combining agents.

Individualizing treatment to balance ischemic and bleeding risks is essential.

Let the data inform our discussions.”

Title: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation

Authors: Gilles Lemesle, Romain Didier, Philippe Gabriel Steg, Tabassome Simon, Gilles Montalescot, Nicolas Danchin, Christophe Bauters, Didier Blanchard, Claire Bouleti, Denis Angoulvant, Stéphane Andrieu, Gérald Vanzetto, Mathieu Kerneis, Véronique Decalf, Etienne Puymirat, Dominique Mottier, Abdourahmane Diallo, Eric Vicaut, Martine Gilard, Guillaume Cayla

Mital Jhaveri: Do Heart Failure Patients on Anticoagulants Still Need Aspirin?

Stay updated on all scientific advances with Hemostasis Today.

Abdourahmane Diallo American Heart Association anticoagulants Aspirin Cardiology Christophe Bauters Claire Bouleti Denis Angoulvant Didier Blanchard Dominique Mottier Eric Vicaut Etienne Puymirat Gérald Vanzetto Gilles Lemesle Gilles Montalescot Guillaume Cayla Health Hematology Hemostasis Hemostasis News Hemostasis Today Martine Gilard Mathieu Kerneis Medicine Mital Jhaveri NEJM Nicolas Danchin Philippe Gabriel Steg Romain Didier Stéphane Andrieu Tabassome Simon Véronique Decalf
NewsFeed